These included BMI ≤ 23.0 kg/m2, two underlying comorbidities (cardiovascular diseases and immunocompromised state), and three laboratory parameters on day 14 of MV (platelet count < 150 × 103/μL, PaO2/FiO2 ≤ 200 mmHg, and albumin ≤ 2.8 g/dL) (Table 3). The gene discussed is ALB; the disease is cardiovascular disorder.